Please excuse my usual ignorance but..... If the consortium (or any) test is less than 100% reliable, would testing twice or more increase the possibility of detecting the antibody or would it be user specific and the same results be repeated in subsequent tests for each individual regardless?
Just thinking of increased unit sale numbers if this was at all the case?
Thanks in advance for putting me straight on this if possible.
Exactly the point Ganners. I had an excited message from Formula 1 management this morning about the Roche test being a “game changer” for the continuity of the sport. They will be far more excited about the RTC test which I have informed them of. This is just one example of how under the radar ODX and co are but this will change dramatically in our favour over the coming days and weeks.